Pacing Optimized by Left Ventricular dP/dtmax

Card Electrophysiol Clin. 2022 Jun;14(2):223-232. doi: 10.1016/j.ccep.2021.12.002. Epub 2022 May 25.

Abstract

Left ventricular (LV) dP/dtmax provides a sensitive measure of the acute hemodynamic response to cardiac resynchronization therapy (CRT) and can predict reverse remodeling on echocardiography. Its use to guide LV lead placement has been shown to improve outcomes in a multicenter randomized trial. Given the invasive protocol required for measurement, it is unlikely to be universally beneficial for patients undergoing CRT but may be useful for patients who do not respond to conventional CRT, or in those who have borderline indications or risk factors for non-response. In such cases, LV dP/dtmax may help guide LV lead placement, optimize device programming, and select the best alternative method of delivering CRT, such endocardial LV pacing or conduction system pacing.

Keywords: Acute hemodynamic response; Cardiac resynchronization therapy; Conduction system pacing; Device optimization; Endocardial left ventricular pacing; Multipoint pacing; Multisite pacing; Pressure wire.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy* / methods
  • Echocardiography
  • Heart Failure* / therapy
  • Heart Ventricles / diagnostic imaging
  • Hemodynamics / physiology
  • Humans
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Treatment Outcome